YiChang HEC ChangJiang Pharmaceutical

OverviewSuggest Edit

YiChang HEC ChangJiang Pharmaceutical is a company that develops, manufactures, and sells pharmaceutical products. It focuses on virus infections, endocrine, metabolic, and cardiovascular diseases. The company offers its products in the form of capsules and granules.

TypePublic
Founded2001
Websitecj.hec.cn

Latest Updates

Employees (est.) (Jun 2019)4,595
Share Price (Oct 2021)$4.1(-4%)
Cybersecurity ratingBMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

YiChang HEC ChangJiang Pharmaceutical Financials and Metrics

YiChang HEC ChangJiang Pharmaceutical Revenue

Market capitalization (15-Oct-2021)

3.6b

Closing stock price (15-Oct-2021)

4.1
YiChang HEC ChangJiang Pharmaceutical's current market capitalization is $3.6 b.
Show all financial metrics

YiChang HEC ChangJiang Pharmaceutical Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

YiChang HEC ChangJiang Pharmaceutical Online and Social Media Presence

Embed Graph

YiChang HEC ChangJiang Pharmaceutical Frequently Asked Questions

  • When was YiChang HEC ChangJiang Pharmaceutical founded?

    YiChang HEC ChangJiang Pharmaceutical was founded in 2001.

  • How many employees does YiChang HEC ChangJiang Pharmaceutical have?

    YiChang HEC ChangJiang Pharmaceutical has 4,595 employees.

  • Who are YiChang HEC ChangJiang Pharmaceutical competitors?

    Competitors of YiChang HEC ChangJiang Pharmaceutical include Livzon Pharmaceutical Group, Cipla and Genentech.